Fecal Incontinence Market to Partake Significant Development by 2025

Fecal incontinence is associated with the inability of individuals to control bowel movements, causing unexpected leakage of stool leading to complete loss of bowel control. Fecal incontinence is also known as bowel incontinence. It is caused due to constipation, diarrhea, and nerve damage which is linked with aging. Fecal incontinence is of two types: urge incontinence (an individual is not able to resist the urge to excrete) and passive incontinence (an individual is not aware of the sensation before soiling oneself).

Fecal incontinence diagnosis is carried out through medical examination test, which include digital rectal examination, balloon expulsion test, anal manometry, proctography, proctosigmoidoscopy, colonoscopy, and magnetic resonance imaging (MRI). Treatment of fecal incontinence involves usage of anti-diarrheal drugs such as loperamide hydrochloride, laxatives (psyllium), and injectable bulking agents such as hyaluronate sodium.

Surgery can also be prescribed in certain adverse cases. Different types of surgical procedures used to treat fecal incontinence are sphincteroplasty, surgical correction of rectocele or hemorrhoids, sphincter replacement, colostomy, or bowel diversion. Around 1.4% of the general population over 40 years of age is affected by fecal incontinence and nearly 3% to 15% of the population is affected by constipation. According to the Continence Foundation of Australia, nearly 4.8 million people in Australia experience bladder or bowel control problems. Fecal incontinence affects nearly 20% of men and approximately 12.9% of women in Australia.

Request to View Brochure of Report –

https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=33698

Major drivers of the global Fecal Incontinence Market are increase in prevalence of diseases which result in the loss of muscle control and lead to gastrointestinal disorders, rise in the pharmaceutical industry, surge in demand for fecal incontinence products, growing awareness about personal hygiene, rise in geriatric population, and technological innovation in continence product development. Factors restraining the market are social stigma, emotional distress, increasing cost of health care suppliers, inadequate knowledge about the treatment of fecal incontinence in developing countries, and stringent regulations and reimbursement policies.